Role of metabolic manipulator trimetazidine in limiting percutaneous coronary intervention–induced myocardial injury

BACKGROUND: Trimetazidine (TMZ) is a metabolic modulator that shifts substrate utilization from fatty acid to carbohydrates, thereby, increasing myocardial glucose oxidation and improving myocardial ischemia. We evaluated whether TMZ is effective in reducing myocardial injury after percutaneous coro...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Indian Heart J
Hauptverfasser: Kazmi, Danish H., Kapoor, Aditya, Sinha, Archana, Ambesh, Paurush, Kashyap, Shiridhar, Khanna, Roopali, Kumar, Sudeep, Garg, Naveen, Tewari, Satyendra, Goel, Pravin K.
Format: Artigo
Sprache:Inglês
Veröffentlicht: Elsevier 2018
Schlagworte:
Interventional Cardiology
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6309873/
https://ncbi.nlm.nih.gov/pubmed/30595291
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ihj.2018.10.415
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge